ABSTRACT There are seven ribosomal RNA operons (rrn operons) in E8cherichia coli A single rrn operon was amplified by use of a multicopy recombinant plasmid containing a complete rrnfH operon. rrnH thereby has the potential to contribute a greater fraction of the rRNA found in ribosomes. Erythromycinresistant mutants were isolated-from cells containing the plasmid, and at least one mutation to resistance was shown to reside in rrnH on the plasmid. Erythromycin resistance was retained when a major deletion was introduced into the 16S rRNA gene and was abolished by deletions that affect the 16S and 23S rRNA genes but do not alter the 5S rRNA gene or non-rmH DNA. Cell-free S30 protein-synthesizing extracts from cells containing the mutant plasmid have an increased resistance to erythromycin. The selection procedure used to isolate erythromycin-resistance mutations in rrnH may allow, with minor modifications, the isolation of mutations in rrn operons that change resistance of the ribosome to other antibiotics or that alter other properties of ribosomes.
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The presence of seven rrn operons in Escherichia coli may be responsible for the inability to isolate mutations in rRNA genes because a single mutant rRNA gene can contribute rRNA to only a fraction of the total ribosomes and might not result in an observable phenotypic change in the bacterium. Resistance to many antibiotics, including erythromycin, is recessive or weakly codominant to sensitivity when the resistance mutation alters ribosomal proteins (1) (2) (3) . Dominance ofsensitivity is best documented for streptomycin-resistance mutations, in which streptomycin-resistant/streptomycin-sensitive merodiploids contain ribosomes of both normal and altered types and are still nearly as sensitive to the bacteriocidal and bacteriostatic activities of streptomycin as are streptomycin-sensitive cells (1, 3) . Therefore, a mutation in a rRNA gene also might go undetected due to dominance ofsensitive ribosomes that contain rRNA synthesized from nonmutant rrn operons in the same cell.
In yeast mitochondria, which have only a single set of rRNA genes, mutations in the large rRNA gene can give rise to chloramphenicol resistance (rib-i), erythromycin resistance (rib-3), and erythromycin and spiromycin resistance (rib-2) (4, 5) . It remains possible that paromomycin resistance in yeast mitochondria results from a mutation in the gene for the small rRNA (5) . Chloramphenicol resistance, has been shown, by sequence analysis, to result from a DNA sequence alteration in the rRNA genes ofthe mitochondria ofyeast (6) and mice (7) . Kasugamycin resistance in E. coli can result from a mutation in a methylase that modifies 16S rRNA (8) . Thiostrepton resistance in Streptomyces (9) and erythromycin resistance in Staphylococcus, Streptococcus (10), and Streptomyces (11) are due to methylation ofthe 23S rRNA ofthese organisms. Mutations to viomycin resistance in Mycobacterium smegmatis, a bacterium that contains a single set of rRNA genes, can alter both large rRNAs in some way (12) .
In all these cases the alterations of rRNA result either from a mutation in an rRNA gene in a system with a single set of rRNA genes or from the effect of an enzyme capable of modifying all rRNA molecules. These examples prove that rRNA is involved in the interaction of antibiotics with ribosomes and suggest that the previous failure to isolate antibiotic resistance mutations in rrn operons of E. coli was due to the repetition of rRNA genes.
We therefore sought to isolate mutations in an rrn operon which is present on a multicopy plasmid and can therefore contribute a greater percentage of the rRNA in cells. In this paper we report the isolation of an erythromycin-resistance mutation in rrnH.
MATERIALS AND METHODS
Bacterial Strains and Plasmids. The bacterial strains used were EM2 (ilvi his29 pro2 tsx trpA9605 trpR ara F+), W3110 (NalRF-), and EM4 (a recA derivative of EM2). The plasmid used to obtain the mutation described in this paper is pLC7-21, which contains rrnH on a ColEl vector. pLC7-21 confers immunity to colicin El and is mobilizable by F (13). The restriction nuclease maps ofpLC7-21 and its derivatives were determined by standard methods (14) and are in agreement with the restriction nuclease cleavage sites predicted by the partial DNA sequence of rrnH (15) (16) (17) and by examination of the complete nucleotide sequence of rrnB (18) . pERY-1 is a derivative of pLC7-21 that confers erythromycin resistance. pERY-Dl is derived from pERY-l by in vitro deletion of DNA between the Sal I recognition sites in the 16S and 23S rRNA genes, and pERY-D2 is derived from pERY-1 by in vitro deletion of DNA between the two HindIII sites in the 16S rRNA gene (see Fig.  1 ). Colicin El was purified from W3110/ColEl through the ammonium sulfate precipitation steps of Schwartz and Helinski (19) A filter paper disk soaked in methanesulfonic acid ethyl ester was placed in the middle of the dish. After 1 day many colonies had appeared, overgrowing a weak lawn. The cells were washed offthe plate, diluted to an OD550 of0.2 in LB plus erythromycin (100 pug/ml), and grown overnight. Erythromycin at 100 ug/ ml was used at this stage to allow additional opportunity for phenotypic expression under a stronger selection for erythromycin resistance. The cells were then centrifuged, washed with LB, resuspended in LB to an OD550 of0.05, grown to an 0D550 of0.2, and then mixed with an equal volume ofgrowing W3110 at the same cell density. The mating mixture was incubated overnight at 370C in a thin layer at the bottom of a stationary flask, diluted 1:20 in LB plus nalidixic acid (20 pug/ml), grown overnight, and plated on LB plus colicin El, nalidixic acid (20 ,tg/ml), and erythromycin (100 gg/ml). Many colonies grew on these plates, but none grew on controls with only EM2/ pLC7-21 or W3110. All colonies were identified as W3110/ pLC7-21 derivatives when checked for nonselected nutritional markers, immunity to colicin El, sensitivity to phage BF23 (which shares the colicin El receptor), and resistance to 300 ,g of erythromycin per ml. Only colonies resistant to this concentration of erythromycin were further analyzed. Bradford (22) , 1 .0 /iCi (1 Ci = 3.7 X 10" becquerels) of [3H]leucine (500 Ci/mol), erythromycin when desired, and all other components specified by Nathans (21) except mRNA. The extract was incubated for 5 min at 37TC before addition of25 ,ug of MS2 RNA (purchased from Boehringer). After incubation for an additional 40 min, the amount of [3H]leucine incorporated into protein was determined (21) . The protein synthesized in identical reaction mixtures without MS2 RNA was subtracted from each value.
RESULTS
Isolation ofpERY-1. pLC7-21 is a recombinant plasmid (Fig.  1) that contains rrnH on a ColEl vehicle (13) . rrnH has the gene order promotor-promotor-16S rRNAAtRNAIIe-tRNAAl a y23S rRNA-5S rRNA-tRNAiAsP-terminator (14) (15) (16) (17) . A mutation was isolated on pLC7-21 to give rise to pERY-1. Erythromycin resistance was found to cotransfer and to cosegregate with the colicin immunity encoded by pERY-1.
Characterization of pERY-1. In the presence of erythromycin at 300 ,utg/ml, EM2/pERY-1 grew well at 30'C, 370C, or 420C; EM2/pLC7-21 did not grow at all (Fig. 2) . On medium without erythromycin, cells containing either pERY-1 or pLC7-21 grew at the same rate, but on medium with erythromycin cells containing pERY-1 grew noticeably slower than they did on the same medium without erythromycin. pERY-1 also conferred resistance to erythromycin when present in EM4, a recA derivative ofEM2. Therefore, erythromycin resistance does not require alteration of chromosomal rrn sequences by recombination events or gene conversion events involving the plasmid. Because all colonies tested that arose from cells recently transformed with pERY-1 (selected by colicin immunity) were erythromycin resistant, it is unlikely that inactivation ofchromosomal rrn sequences is a prerequisite for erythromycin resistance. Therefore, erythromycin resistance due to the mutation on pERY-1 is dominant or codominant over erythromycin sensitivity due to the seven chromosomal rrn sequences.
Although we have not analyzed in great detail the response ofEM2/pERY-1 to increased levels oferythromycin, its plating efficiency was decreased at levels of erythromycin above 400 ,g/ml, although surviving colonies grew reasonably well. Plating efficiency of EM2/pERY-1 was well above that of EM2/ pLC7-21 up to at least 2,000 ,ug of erythromycin per ml. It is possible that a complex interplay among plasmid copy number, antibiotic-caused plasmid amplification, phenotypic lag in the percentage of antibiotic-resistant ribosomes, and inhibition of protein synthesis by erythromycin underlies the observed downward trend in plating efficiency with increasing concentrations of erythromycin.
Deletion Analysis of pERY-l. The erythromycin-resistance mutation in pERY-1 was localized by analysis of deletions pro- pERY-1 (B) , pERY-D1 (C), or pERY-D2 (D) on LB agar plus colicin El with and without erythromycin at 300 Ag/ml. Plates were incubated for 2 days at 3700. duced in vitro by restriction nucleases (Fig. 1) .. Deletions ofrrn operons on plasmids that retain the rrn promotors can occur readily only if the rrn termination sequences remain intact (unpublished data). pERY-1 was first digested to completion with Sal I and the resulting mixture of DNA fragments was then ligated at low DNA concentration to favor circularization of individual DNA fragments. The mixture of DNA was used to transform EM2. Many colicin-immune colonies arose, and all were erythromycin sensitive. The DNA from one of these (pERY-DI) was analyzed in detail by use ofrestriction nucleases and found to be the expected simple deletion of the Sal I fragment derived from the center of rrnH (Fig. 1) . The deletion in pERY-D1 removed major portions of the 16S and 23S rRNA genes and all of the tRNAlUe and tRNANla genes. The rrnH promotor, 5S rRNA gene, and tRNAj SP gene remained intact, but we have no evidence that functional 5S rRNA or tRNAMP molecules are synthesized from the altered rrnH operon on pERY-D1 and therefore cannot conclude that the mutation is not in the 5S rRNA or tRNAASP genes. The erythromycin sensitivity of cells containing pERY-D1 proves the erythromycin-resistance mutation is in rrnH.
pERY-1 was then digested to completion with HindIII, which cuts twice in the 16S rRNA gene and once outside of rrnH. The resulting mixture of DNA fragments was ligated. under conditions that favor formation of new plasmids. containing multiple HindIII fragments. The ligated DNA was transformed into EM2 and the products were. selected for colicin immunity. The colonies were then replica plated onto medium containing 300 Ug oferythromycin per ml. Ten percent ofthe colonies were erythromycin resistant. Plasmids from five erythromycin-resistant colonies were analyzed by restriction nucleases and found to have deletions ofthe 450-basepair HindIII fragment containing a portion of the 16S rRNA gene, and had 'the HindIII fragment containing the distal portion of rrnH ligated in an orientation that allowed all remaining portions ofrrnH to be expressed from the rrnH promotor.
One of these plasmids, pERY-D2 (Fig. 1) , was analyzed in further detail. This selection for fragment retention in a single orientation was expected if the erythromycin-resistance mutation isolated in rrnH on pERY-1 was in the 23S or 5S rRNA genes or tRNA genes, but it.also may have occurred if the rrnH transcription. termination signal must properly terminate transcripts from the rrnH promotor so that transcription does not interfere with plasmid replication. The deletion in pERY-D2 proves that the mutation is not in the 16S rRNA gene. The properties ofpERY-1, pERY-D1, and pERY-D2, in conjunction with previous observations on the mechanisms of erythromycin resistance and erythromycin action on ribosomes, strongly suggest, but do not absolutely prove, that the erythromycin-resistance mutation is in the 23S rRNA gene of rrnH.
The. presence of pERY-D1 or pERY-D2 in cells may result in abortive assembly of ribosomal subunits due to the partial rRNA molecules produced from these plasmids. The deletion in pERY-D2 may cause an unbalanced synthesis of rRNA because this plasmid. contains a major deletion in the 16S rRNA gene and probably produces 23S rRNA (because the plasmid confers erythromycin resistance). Adding erythromycin to cells containing pERY-1 or pERY-D2 probably will rapidly alter the ratio of small ribosomal subunits to functional large ribosomal subunits. In the absence of erythromycin,, cells containing pERY-1, pERY-D1, or pERY-D2 grew at similar rates (Fig. 2) .
This indicates that either an imbalance of synthesis or accumulation of rRNA or ribosomes does not occur or that the imbalances that do occur under these conditions are not strongly inhibitory to cell growth. However, in the presence of erythromycin, cells containing pERY-D2 grew noticeably better than cells containing pERY-1. This may be because, for cells growing in erythromycin, the ratio offunctional large ribosomal subunits to small ribosomal subunits is closer to unity in cells containing pERY-D2 than in cells containing pERY-1.
Protein Synthesis in S30 Extracts. When extracts were prepared from EM2/pERY-1 and EM2/pLC7-21 grown in the absence of erythromycin, protein synthesis by extracts from EM2/pERY-1 had increased resistance to erythromycin compared to extracts from EM2/pLC7-21 (Fig. 3) . The response to erythromycin observed in extracts from EM2/pERY-1 is compatible with the existence of a fraction of ribosomes with increased resistance to erythromycin or the presence in these cells ofa fraction (or all) ofribosomes partially resistant to erythromycin. The observed level of resistance in extracts may not completely reflect the level oferythromycin resistance in EM2/ pERY-1 because it is possible that the fraction oferythromycinresistant ribosomes in EM2/pERY-1 grown on erythromycin may be much higher than in these extracts due to erythromycininduced plasmid amplification (see below) and selection against plasmid segregation. Because these experiments used S30 extracts, they show that the erythromycin resistance is not due to alteration ofthe permeability ofcells to erythromycin. These in vitro experiments by themselves do not identify the ribosome Proc. Natl. Acad. Sci. USA 79 (1982) or rRNA as the site of the alteration that confers erythromycin resistance. (1) (2) (3) . Indeed, although cells containing pERY-1 can grow at erythromycin concentrations of at least 2,000 ,ug/ml, the plating efficiency decreases markedly with increasing erythromycin concentration.
DISCUSSION
In E. coli, erythromycin is a bacteriostatic antibiotic (24) that binds with high affinity to a single site on the large ribosomal subunit (25) . Erythromycin is probably an inhibitor of the peptidyltransferase activity of the large ribosomal subunit. However, the action of erythromycin appears to be complex when analyzed in the framework of existing models of ribosome action, and inhibition of other ribosome functions cannot be ruled out (9) . Previous ribosomal mutations to erythromycin resistance were either in genes for ribosomal proteins L4 or L22 (26) or in another gene (eryC) that may affect both ribosomal subunits (27) . Mutations in ribosomal proteins S5 and S12 of the small subunit can also affect erythromycin binding to the large subunit (28) .
In ribosome reconstitution studies, ribosomal proteins L15 and L16 were necessary to bind erythromycin to the ribosome. Purified L15 alone can bind erythromycin, but with lower affinity than L15 and L16 in ribosomal particles (29) . In the 50S ribosomal assembly map of Rohl and Nierhaus (30), L4 binds 23S rRNA strongly, L22 has a weak binding dependence on 23S rRNA, L22 and L15 have a strong binding dependence on the previous binding ofL4, and L16 interacts weakly with 23S rRNA and depends strongly on previous binding of L15. L4, L15, and L16 are three of the five proteins identified by Rohl and Nierhaus (30) as proteins essential for reconstitution of peptidyltransferase activity.
Because these proteins are involved in erythromycin action on the ribosome and in some cases interact with rRNA, it seems likely that potentially complex interactions between rRNA and ribosomal proteins are involved in the action of erythromycin and in the function or structure ofthe peptidyltransferase region of the ribosome. Sequence analysis of the mutation isolated in rrnH in the present work and alterations in 23S rRNA molecules observed in erythromycin-resistant mitochondria and bacteria (4, 5, 10, 11) may partially clarify functional and structural interactions in the region of the ribosome affected by erythromycin. When mutations to erythromycin resistance are in ribosomal protein genes, sensitivity is dominant over resistance (2) . Because cells with pERY-1 can grow in the presence of erythromycin, the mutation on pERY-1 must be dominant or codominant, at least when on a multicopy plasmid. The reason for the difference in dominance between mutations in ribosomal protein genes and this mutation in rrnH remains to be determined. If the mutation proves to be in the 23S rRNA gene (as is likely but not completely proven; see above) then E. coli containing pERY-1 must be capable of growing in the presence of ervthromycin when most or all protein synthesis is directed by ribosomes containing 23S rRNA from rrnH. This suggests that all 23S rRNA genes are functionally similar. The erythromycin resistance of cells containing pERY-D2, a plasmid with a 470-base-pair deletion in the 16S rRNA gene, suggests that erythromycin resistance (and therefore probably large ribosomal subunit assembly) using rRNA from rrnH is not dependent on any aspects of small ribosomal subunit assembly that are blocked by the deletion in the 16S rRNA gene of rrnH. However, there may be an assembly dependence of large subunits containing rRNA from rrnH on assembly of small subunits containing 16S rRNA from other rrn operons.
